Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | June 25, 2026 | June 29, 2026 |
| Dime Commercial Bancshares, Inc. /NY/DCOM · Entity 4607 | Director | March 31, 2023 | April 04, 2023 |
| Stem Holdings, Inc.STMH · Entity 109845 | Director | May 07, 2021 | October 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 3,344 |
Reported balance
After 2026-06-25 transaction · row 1
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 645 · Balance 3,344 F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.
Dime Commercial Bancshares, Inc. /NY/
Report date March 31, 2023 · Filed April 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 90,150.89 |
Reported balance
After 2023-03-31 transaction · row 1
1 source rowRow 1 · 2023-03-31 · Grant · Acquired 2,889 · Balance 90,150.89 F1: Restricted Stock Award. Award cliff vests on the one year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Award. Award cliff vests on the one year anniversary of the date of grant.
Stem Holdings, Inc.
Report date May 07, 2021 · Filed October 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 450,000 |
Ending reported balance
After 2021-03-31 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2019-05-07 · Grant · Acquired 75,000 · Balance 75,000 Row 2 · 2019-12-31 · Grant · Acquired 62,500 · Balance 137,500 Row 3 · 2020-03-31 · Grant · Acquired 62,500 · Balance 200,000 Row 4 · 2020-06-30 · Grant · Acquired 62,500 · Balance 262,500 Row 5 · 2020-09-30 · Grant · Acquired 62,500 · Balance 325,000 Row 6 · 2020-12-30 · Grant · Acquired 62,500 · Balance 387,500 Row 7 · 2021-03-31 · Grant · Acquired 62,500 · Balance 450,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2024-01-14 | Direct | 250,000 |
Reported balance
After 2020-01-14 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-01-14 · Grant · Acquired 250,000 · Balance 250,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.40 · Expires 2025-06-10 | Direct | 250,000 |
Reported balance
After 2021-06-11 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-06-11 · Grant · Acquired 250,000 · Balance 250,000 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NAVISTAR INTERNATIONAL CORP
Report date July 01, 2021 · Filed July 06, 2021
Section 16 reporting ended · disclosed 2021-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-07-01 transaction · row 1
1 source rowRow 1 · 2021-07-01 · Disposition to issuer · Disposed 7,515 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 7, 2020 (the "Merger Agreement"), by and among Navistar International Corporation, a Delaware Corporation (the "Issuer"), TRATON SE, a Societas Europaea ("TRATON") and Dusk Inc., a Delaware Corporation and a wholly owned indirect subsidiary of TRATON ("Merger Sub"), Merger Sub was merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation and an indirect subsidiary of TRATON (the "Surviving Corporation"). As a result of the Merger, each share of Issuer Common Stock was automatically converted into the right to receive an amount in cash equal to $44.50 (the "Merger Consideration"). |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.31 · Expires 2028-12-11 | Direct | 0 |
Reported balance
After 2021-07-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-07-01 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.63 · Expires 2027-12-12 | Direct | 0 |
Reported balance
After 2021-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-07-01 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. |
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.94 · Expires 2026-12-13 | Direct | 0 |
Reported balance
After 2021-07-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-07-01 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 7, 2020 (the "Merger Agreement"), by and among Navistar International Corporation, a Delaware Corporation (the "Issuer"), TRATON SE, a Societas Europaea ("TRATON") and Dusk Inc., a Delaware Corporation and a wholly owned indirect subsidiary of TRATON ("Merger Sub"), Merger Sub was merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation and an indirect subsidiary of TRATON (the "Surviving Corporation"). As a result of the Merger, each share of Issuer Common Stock was automatically converted into the right to receive an amount in cash equal to $44.50 (the "Merger Consideration").
F2: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2026 Filed Jun 29, 2026 20:25 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 645 | $225.00 | $145,125.00 |
DisclosureSEC source: 0001361519-26-000003 · wk-form4_1782764715.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,344 F1 · kind: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 18:03 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 748 | $300.00 | $224,400.00 |
DisclosureSEC source: 0001628280-26-006282 · wk-form4_1770660210.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,699 Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:23 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 532 | $273.03 | $145,251.96 |
DisclosureSEC source: 0001156375-25-000145 · wk-form4_1750976618.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,447 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:17 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,000 | $271.28 | $271,280.00 |
DisclosureSEC source: 0001156375-25-000107 · wk-form4_1746044231.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,915 F1 · price: On April 29, 2025, Mr. Suskind sold an aggregate of 1,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $271.24 to $271.33. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 00:46 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 748 | $194.10 | $145,186.80 |
DisclosureSEC source: 0001156375-24-000125 · wk-form4_1719449204.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,915 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| November 06, 2023 Filed Nov 7, 2023 12:38 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,500 | $213.60 | $320,400.00 |
DisclosureSEC source: 0001156375-23-000194 · wk-form4_1699360706.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,167 Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 16:17 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 811 | $178.89 | $145,079.79 |
DisclosureSEC source: 0001156375-23-000105 · wf-form4_168796904044600.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,667 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 15:20 UTC | Dime Commercial Bancshares, Inc. /NY/ DCOM · Entity 4607 | GrantCommon | 2,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003304 · primarydocument.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,150.89 F1 · shares: Restricted Stock Award. Award cliff vests on the one year anniversary of the date of grant. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 14:32 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 693 | $209.44 | $145,141.92 |
DisclosureSEC source: 0001156375-22-000198 · wf-form4_165651313056562.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,856 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 14:37 UTC | Dime Commercial Bancshares, Inc. /NY/ DCOM · Entity 4607 | GrantCommon | 1,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-003198 · primarydocument.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,261.89 F1 · shares: Restricted Stock Award. Award cliff vests on the one year anniversary of the date of grant. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:18 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000019 · wf-form4_164322831803715.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,163 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:53 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | Disposition to issuerStock Options (Right to buy) · Derivative | 5,000 | $13.56 Strike: $30.94 | $67,800.00 |
DisclosureSEC source: 0000808450-21-000067 · wf-form4_162561919145275.xml · derivative · entry 4 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2026-12-13 F2 · kind: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · price: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:53 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | Disposition to issuerStock Options (Right to buy) · Derivative | 5,000 | $2.87 Strike: $41.63 | $14,350.00 |
DisclosureSEC source: 0000808450-21-000067 · wf-form4_162561919145275.xml · derivative · entry 3 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2027-12-12 F2 · kind: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · price: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:53 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | Disposition to issuerStock Options (Right to buy) · Derivative | 5,000 | $17.19 Strike: $27.31 | $85,950.00 |
DisclosureSEC source: 0000808450-21-000067 · wf-form4_162561919145275.xml · derivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2028-12-11 F2 · kind: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · price: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, each option to purchase shares of common stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 20:53 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | Disposition to issuerCommon Stock | 7,515 | $44.50 | $334,417.50 |
DisclosureSEC source: 0000808450-21-000067 · wf-form4_162561919145275.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to that certain Agreement and Plan of Merger, dated as of November 7, 2020 (the "Merger Agreement"), by and among Navistar International Corporation, a Delaware Corporation (the "Issuer"), TRATON SE, a Societas Europaea ("TRATON") and Dusk Inc., a Delaware Corporation and a wholly owned indirect subsidiary of TRATON ("Merger Sub"), Merger Sub was merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation and an indirect subsidiary of TRATON (the "Surviving Corporation"). As a result of the Merger, each share of Issuer Common Stock was automatically converted into the right to receive an amount in cash equal to $44.50 (the "Merger Consideration"). F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 7, 2020 (the "Merger Agreement"), by and among Navistar International Corporation, a Delaware Corporation (the "Issuer"), TRATON SE, a Societas Europaea ("TRATON") and Dusk Inc., a Delaware Corporation and a wholly owned indirect subsidiary of TRATON ("Merger Sub"), Merger Sub was merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation and an indirect subsidiary of TRATON (the "Surviving Corporation"). As a result of the Merger, each share of Issuer Common Stock was automatically converted into the right to receive an amount in cash equal to $44.50 (the "Merger Consideration"). Read SEC document |
| June 25, 2021 Filed Jun 30, 2021 01:06 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 551 | $218.12 | $120,184.12 |
DisclosureSEC source: 0001156375-21-000080 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,116 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 11, 2021 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantOptions · Derivative | 250,000 | $0.10 Strike: $0.40 | $25,000.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · derivative · entry 9 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2025-06-10 Read SEC document |
| March 31, 2021 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantCommon Stock | 62,500 | $0.45 | $28,125.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · nonDerivative · entry 7 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 09:54 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | SaleCommon Stock | 4,769 | $44.04 | $210,026.76 |
DisclosureSEC source: 0000808450-21-000029 · wf-form4_161547448371365.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,515 Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 17:23 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantCommon Stock | 3,389 | $0.00 | $0.00 |
DisclosureSEC source: 0000808450-21-000021 · wf-form4_161489657714535.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,284 Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 17:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,000 | $183.32 | $183,320.00 |
DisclosureSEC source: 0001156375-21-000012 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,565 Read SEC document |
| January 19, 2021 Filed Jan 20, 2021 11:00 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | SaleCommon Stock | 2,500 | $43.96 | $109,901.00 |
DisclosureSEC source: 0000808450-21-000004 · wf-form4_161115843251816.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,895 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.96 to $43.965, inclusive. The reporting person undertakes to provide Navistar International Corporation ("Navistar"), any security holder of Navistar, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| December 30, 2020 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantCommon Stock | 62,500 | $0.45 | $28,125.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · nonDerivative · entry 6 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,500 Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 11:03 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | SaleCommon Stock | 2,000 | $44.00 | $88,000.00 |
DisclosureSEC source: 0000808450-20-000109 · wf-form4_160917136734188.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,395 Read SEC document |
| September 30, 2020 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantCommon Stock | 62,500 | $0.43 | $26,875.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · nonDerivative · entry 5 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,000 Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 14:37 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,000 | $174.61 | $349,220.00 |
DisclosureSEC source: 0001156375-20-000086 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,565 Read SEC document |
| June 30, 2020 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantCommon Stock | 62,500 | $0.42 | $26,250.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · nonDerivative · entry 4 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,500 Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:15 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000069 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,565 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| March 31, 2020 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantCommon Stock | 62,500 | $0.40 | $25,000.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · nonDerivative · entry 3 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 18:01 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantCommon Stock | 4,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000808450-20-000032 · wf-form4_158275806186384.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,395 Read SEC document |
| January 14, 2020 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantOptions · Derivative | 250,000 | $1.00 Strike: $1.00 | $250,000.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · derivative · entry 8 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2024-01-14 Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 17:53 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantCommon Stock | 1,253 | $0.00 | $0.00 |
DisclosureSEC source: 0000808450-20-000002 · wf-form4_157800556558679.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,270 Read SEC document |
| December 31, 2019 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantCommon Stock | 62,500 | $0.44 | $27,500.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · nonDerivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,500 Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 14:00 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantCommon Stock | 1,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000808450-19-000213 · wf-form4_156995279535877.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,017 Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 19:17 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,500 | $212.46 | $318,690.00 |
DisclosureSEC source: 0001156375-19-000090 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,853 F1 · price: On August 9, 2019, Mr. Suskind sold an aggregate of 1,500 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $212.32 to $212.71. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 12:20 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantCommon Stock | 1,052 | $0.00 | $0.00 |
DisclosureSEC source: 0000808450-19-000159 · wf-form4_156208440721236.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,727 Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 19:32 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 606 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000071 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,353 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| May 07, 2019 Filed Oct 22, 2021 10:06 UTC | Stem Holdings, Inc. STMH · Entity 109845 | GrantCommon Stock | 75,000 | $0.42 | $31,500.00 |
DisclosureSEC source: 0001493152-21-026036 · ownership.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 13:07 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantCommon Stock | 1,122 | $0.00 | $0.00 |
DisclosureSEC source: 0000808450-19-000097 · wf-form4_155431121343356.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,675 Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 13:05 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | Exercise / conversionPhantom Stock Units · Derivative | 3,170.782 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000808450-19-000044 · wf-form4_155172269333602.xml · derivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,170.782 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Conversion is on a 1 for 1 basis. F1 · price: Each phantom stock unit was the economic equivalent of one share of Navistar International Corporation Common Stock. The phantom stock units were settled for shares of Navistar International Corporation Common Stock. The fractional phantom stock unit will be reimbursed for cash. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 13:05 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | Exercise / conversionCommon Stock | 3,170 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000808450-19-000044 · wf-form4_155172269333602.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each phantom stock unit was the economic equivalent of one share of Navistar International Corporation Common Stock. The phantom stock units were settled for shares of Navistar International Corporation Common Stock. The fractional phantom stock unit will be reimbursed for cash. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 13:09 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantPhantom Stock Units · Derivative | 1,252.409 | $25.95 Strike: $0.00 | $32,500.01 |
DisclosureSEC source: 0000808450-19-000002 · wf-form4_154653894679374.xml · derivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,252.409 Underlying: Common Stock · 1,252.409 shares Expires 2018-12-31 F1 · derivative.exercise_price: Conversion is on a 1 for 1 basis. F2 · derivative.exercise_date: The phantom stock units were accrued under the Navistar International Corporation directors' deferred compensation plan and are to be settled in Navistar Common Stock per the reporting person's election made at the time of the election to defer compensation. F2 · derivative.expiration_date: The phantom stock units were accrued under the Navistar International Corporation directors' deferred compensation plan and are to be settled in Navistar Common Stock per the reporting person's election made at the time of the election to defer compensation. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 17:28 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantStock Options (Right to buy) · Derivative | 5,000 | $0.00 Strike: $27.31 | $0.00 |
DisclosureSEC source: 0000808450-18-000203 · wf-form4_154465366720203.xml · derivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2028-12-11 F1 · derivative.exercise_date: The option is exercisable in three equal installments as follows: 1,667 shares on 12/11/2019; 1,666 shares on 12/11/2020; and 1,667 shares on 12/11/2021 Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 13:47 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantPhantom Stock Units · Derivative | 844.156 | $38.50 Strike: $0.00 | $32,500.01 |
DisclosureSEC source: 0000808450-18-000172 · wf-form4_153850241970149.xml · derivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 844.156 Underlying: Common Stock · 844.156 shares Expires 2018-09-30 F1 · derivative.exercise_price: Conversion is on a 1 for 1 basis. F2 · derivative.exercise_date: The phantom stock units were accrued under the Navistar International Corporation directors' deferred compensation plan and are to be settled in Navistar Common Stock per the reporting person's election made at the time of the election to defer compensation. F2 · derivative.expiration_date: The phantom stock units were accrued under the Navistar International Corporation directors' deferred compensation plan and are to be settled in Navistar Common Stock per the reporting person's election made at the time of the election to defer compensation. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:17 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 87 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000119 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,747 F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 10:40 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantPhantom Stock Units · Derivative | 787.339 | $40.72 Strike: $0.00 | $32,060.44 |
DisclosureSEC source: 0000808450-18-000092 · wf-form4_153062881397707.xml · derivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 787.339 Underlying: Common Stock · 787.339 shares Expires 2018-06-30 F1 · derivative.exercise_price: Conversion is on a 1 for 1 basis. F2 · derivative.exercise_date: The phantom stock units were accrued under the Navistar International Corporation directors' deferred compensation plan and are to be settled in Navistar Common Stock per the reporting person's election made at the time of the election to defer compensation. F2 · derivative.expiration_date: The phantom stock units were accrued under the Navistar International Corporation directors' deferred compensation plan and are to be settled in Navistar Common Stock per the reporting person's election made at the time of the election to defer compensation. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 17:43 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000073 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,660 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 19:27 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantPhantom Stock Units · Derivative | 286.878 | $34.97 Strike: $0.00 | $10,032.12 |
DisclosureSEC source: 0000808450-18-000045 · wf-form4_152279801807252.xml · derivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286.878 Underlying: Common Stock · 286.878 shares Expires 2018-04-01 F1 · derivative.exercise_price: Conversion is on a 1 for 1 basis F2 · derivative.exercise_date: The phantom stock units were accrued under the Navistar International Corporation directors' deferred compensation plan and are to be settled in Navistar Common Stock per the reporting person's election made at the time of the election to defer compensation. F2 · derivative.expiration_date: The phantom stock units were accrued under the Navistar International Corporation directors' deferred compensation plan and are to be settled in Navistar Common Stock per the reporting person's election made at the time of the election to defer compensation. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 19:27 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantCommon Stock | 571 | $0.00 | $0.00 |
DisclosureSEC source: 0000808450-18-000045 · wf-form4_152279801807252.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,383 Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 17:46 UTC | NAVISTAR INTERNATIONAL CORP NAV · Entity 11733 | GrantStock Options (Right to buy) · Derivative | 5,000 | $0.00 Strike: $41.63 | $0.00 |
DisclosureSEC source: 0000808450-17-000130 · wf-form4_151320519482616.xml · derivative · entry 2 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2027-12-12 F1 · derivative.exercise_date: The option is exercisable in three equal installments as follows: 1,667 shares on 12/12/2018; 1,666 shares on 12/12/2019; and 1,667 shares on 12/12/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.